Criteria for use of hypolipidemic agents in adults.
Morales
E
E
College of Pharmacy, Rutgers University, Piscataway, NJ 08855-0789.
Spinler
S A
SA
Wilson
M D
MD
Chin
M M
MM
Jozefiak
E
E
D000328:Adult; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003084:Colestipol / Q000627:therapeutic use; D005260:Female; D015248:Gemfibrozil / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000009:adverse effects / Q000627:therapeutic use; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002792:Cholestyramine Resin; D009525:Niacin; D006903:Hydroxymethylglutaryl CoA Reductases; D003084:Colestipol; D015248:Gemfibrozil